Etan Eigner
Papers
1
Total Citations
1
H-Index
1
About
Dr. Etan Eigner is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes for patients with bladder cancer, with a particular focus on robotic-assisted techniques and perioperative care. His most cited study, “Impact of neoadjuvant chemotherapy on short-term complications following robotic radical cystectomy,” examines the safety and feasibility of combining chemotherapy with robotic surgery—a critical question in modern oncologic urology. By retrospectively analyzing 134 patients who underwent robotic radical cystectomy, Dr. Eigner demonstrated that neoadjuvant chemotherapy does not significantly increase short-term complications, providing reassurance for clinicians pursuing this multimodal treatment pathway. This work contributes to the growing evidence base supporting robotic cystectomy as a standard approach, even in patients receiving systemic therapy. With a citation count reflecting its relevance to practicing urologists and surgical oncologists, Dr. Eigner’s research helps bridge the gap between medical and surgical oncology, ultimately guiding safer, more effective treatment plans for bladder cancer patients. His ongoing investigations continue to refine surgical protocols and improve patient outcomes in the field of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1